Visit us at Medica, Dusseldorf, Germany 17-20 November 2025 at Hall 16, Stand D17-5 and ask us about our free AI tools and the document builder.
Pure Global

HISTOPLASMA CAPSULATUM - ANVISA Registration 82142390001

Access comprehensive regulatory information for HISTOPLASMA CAPSULATUM in Brazil's medical device market through Pure Global AI's free database. This Risk Class II medical device is registered under ANVISA number 82142390001 and manufactured by MIRAVISTA DIAGNOSTICS, LLC. The registration is held by VM BIOMEDICAL LTDA with validity until currently active (VIGENTE).

This page provides complete technical specifications for this device, regulatory compliance details, 2 companies making the same product including IMMY INC, DIASORIN MOLECULAR LLC, and 2 recent registrations in the same technical category. Pure Global AI offers free access to over 100,000+ Brazilian medical device registrations, helping global MedTech companies navigate ANVISA regulations, identify competitors, and discover partnership opportunities efficiently.

Free Database
Powered by Pure Global AI
100,000+ Devices
2 Competitors
2 Recent Registrations
82142390001
Registration Details
ANVISA Registration Number: 82142390001
DJ Fang

DJ Fang

MedTech Regulatory Expert

Need help with 30+ markets registration?

Pricing
Free consultation

Device Details

Famรญlia de teste de LFA de antรญgeno urinรกrio para histoplasma
Risk Class II

Registration Details

82142390001

25351723257202117

35997837000131

Company Information

United States of America
PT: ESTADOS UNIDOS DA AMร‰RICA

Dates and Status

Nov 18, 2021

VIGENTE

09/18/2025 19:00:01

Companies Making Similar Products
Top companies providing products with the same technical name: "HISTOPLASMA CAPSULATUM"